Successful Outcome of Programmed Death 1 Blockade Plus GemOx for Epstein-Barr Virus-Associated Primary Nodal T/NK Cell Lymphoma: A Case Report

Successful Outcome of Programmed Death 1 Blockade Plus GemOx for Epstein-Barr Virus-Associated Primary Nodal T/NK Cell Lymphoma: A Case Report

Epstein-Barr virus (EBV)-associated lymph nodal T/NK cell lymphoma (nodal TNKL) is a rare and aggressive malignancy with an extremely poor prognosis. Although treatments of extranodal NK/T cell lymphoma are frequently reported, the characteristics and pathogenesis of EBV-associated nodal TNKL are di...

Full description

Bibliographic Details
Main Authors:	Liang Xia, Han-Shuo Zhang, Jing Bao, Yu-Chen Zhao, Hai-Long Xia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Oncology
Subjects:	PD-1 blockade case report EBV-associated nodal TNKL tislelizumab Gemcitabine and oxaliplatin
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.706865/full

Similar Items

Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer
by: Hanna Lagenfelt, et al.
Published: (2021-07-01)

Regimen of Azacitidine Combined with GemOx in the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
by: CHEN Xiaojun, et al.
Published: (2022-01-01)

Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma
by: Pauline Gras, et al.
Published: (2012-04-01)

Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature
by: Kishan Soni, et al.
Published: (2020-07-01)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
by: Wook Youn Kim, et al.
Published: (2019-03-01)

Epstein–Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features
by: Charlotte Syrykh, et al.
Published: (2021-07-01)

The addition of tislelizumab to gemcitabine and cisplatin chemotherapy increases thrombocytopenia in patients with urothelial carcinoma: A single‐center study based on propensity score matching
by: Zhimin Gao, et al.
Published: (2023-12-01)

Are Selected Cytokines and Epstein–Barr Virus DNA Load Predictors of Hepatological Complications of Epstein–Barr Virus Infection in Children?
by: Justyna Moppert, et al.
Published: (2023-09-01)

Safety and efficacy of GEMOX plus donafenib and tislelizumab as first‐line therapy for advanced epithelial malignant biliary tract cancer
by: Longrong Wang, et al.
Published: (2023-06-01)

Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial
by: Yanfei Liu, et al.
Published: (2024-03-01)

IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
by: Helen Heslop, et al.
Published: (2009-11-01)

The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinoma
by: Jingwen Zhang, et al.
Published: (2024-02-01)

Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective study
by: Xiang Ren, et al.
Published: (2022-08-01)

NK cell influence on the outcome of primary Epstein Barr virus infection
by: Obinna Chijioke, et al.
Published: (2016-08-01)

Never too old: A case of fatal epstein barr virus pneumonia in an immunocompetent adult
by: Carl Tanba, et al.
Published: (2024-01-01)

Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell Lymphoma
by: Joo Young Ha, et al.
Published: (2020-11-01)

Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine
by: Henry H. Balfour, et al.
Published: (2022-08-01)

Air-Liquid Interface System To Understand Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma
by: Sharon E. Hopcraft, et al.
Published: (2018-08-01)

Stress-Induced Epstein-Barr Virus Reactivation
by: Daniel G. Sausen, et al.
Published: (2021-09-01)

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
by: Mario Henrique M. Barros, et al.
Published: (2023-09-01)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
by: Sanjay de Mel, et al.
Published: (2019-01-01)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
by: Shigeyoshi Fujiwara, et al.
Published: (2019-07-01)

Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation
by: Haiqi Tan, et al.
Published: (2023-08-01)

Cubic ScPd topological metal: Closed nodal line, spin-orbit coupling-induced triply degenerate nodal point–Dirac nodal point transition
by: Yang Li, et al.
Published: (2020-12-01)

The Dual Functions of Andrographolide in the Epstein–Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein–Barr Virus and the Induction of Cell Death
by: Chukkris Heawchaiyaphum, et al.
Published: (2023-11-01)

Determining Chemotherapy Agents in Saliva through Spectrometry and Chromatography Methods Correlated with Periodontal Status in Oncology Patients
by: Diana Cristala Kappenberg Niţescu, et al.
Published: (2021-06-01)

Investigation of Epstein-Barr Virus in Breast Neoplasms in and around the Van Province
by: İbrahim Aras, et al.
Published: (2021-10-01)

Epstein–Barr Virus B Cell Growth Transformation: The Nuclear Events
by: Bo Zhao
Published: (2023-03-01)

Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization
by: Siamak A. Kamranvar, et al.
Published: (2017-08-01)

EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS – TWO HERPES VIRUSES WITH ORAL MANIFESTATIONS.
by: Assya Krasteva
Published: (2013-09-01)

Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein–Barr Virus Relation
by: Miki Takahara, et al.
Published: (2021-06-01)

Epstein Barr virus: Diseases linked to Infection and Transformation
by: Hem Chandra Jha, et al.
Published: (2016-10-01)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
by: Hironori Yoshiyama, et al.
Published: (2012-11-01)

A case of T‐cell‐Epstein–Barr virus‐haemophagocytic lymphohistiocytosis and sustained remission following ruxolitinib therapy
by: Syed Ali, et al.
Published: (2023-01-01)

Comparison of Epstein - Barr virus Antibodies in the serum of patients with Multiple Sclerosis and normal people in Sanandaj, Iran
by: Poorya Foroutan, et al.
Published: (2018-09-01)

Detection of Epstein–Barr virus infection in thymic epithelial tumors by nested PCR and Epstein–Barr-encoded RNA ISH
by: Li Zhao, et al.
Published: (2023-06-01)

Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population
by: Wen-Jie Chen, et al.
Published: (2021-06-01)

Molecular Detection of Epstein - Barr virus in Nasopharyngeal Carcinoma among Sudanese population
by: Ali Edris, et al.
Published: (2016-11-01)

Epstein-Barr DNA in advanced pediatric nasopharyngeal cancer
by: Marlinda Adham, et al.
Published: (2021-09-01)

Epstein-Barr virus: the mastermind of immune chaos
by: Jean de Melo Silva, et al.
Published: (2024-02-01)